The incidence, treatment strategies and outcomes of acute coronary syndromes in the reperfusion network of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECHh) registryWIDIMSKY, Petr; ZELIZKO, Michal; JANSKY, Petr et al.International journal of cardiology. 2007, Vol 119, Num 2, pp 212-219, issn 0167-5273, 8 p.Article

Apixaban in Patients with Atrial FibrillationCONNOLLY, Stuart J; EIKELBOOM, John; TALAJIC, Mario et al.The New England journal of medicine. 2011, Vol 364, Num 9, pp 806-817, issn 0028-4793, 12 p.Article

Apixaban versus Warfarin in Patients with Atrial FibrillationGRANGER, Christopher B; ALEXANDER, John H; CECILIA BAHIT, M et al.The New England journal of medicine. 2011, Vol 365, Num 11, pp 981-992, issn 0028-4793, 12 p.Article

Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007BRUTHANS, Jan; CIFKOVA, Renata; LANSKA, Vera et al.European journal of preventive cardiology (Print). 2014, Vol 21, Num 7, pp 829-839, issn 2047-4873, 11 p.Article

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical OutcomesHYLEK, Elaine M; HELD, Claes; THOMAS, Laine et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 20, pp 2141-2147, issn 0735-1097, 7 p.Article

International differences in in-hospital revascularization and outcomes following acute myocardial infarction: A multilevel analysis of patients in ASSENT-2GUPTA, Milan; CHANG, Wei-Ching; ARMSTRONG, Paul W et al.European heart journal. 2003, Vol 24, Num 18, pp 1640-1650, issn 0195-668X, 11 p.Article

Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular DiseaseVERDECCHIA, Paolo; SLEIGHT, Peter; LISHENG LIU et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 14, pp 1380-1389, issn 0009-7322, 10 p.Article

Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15400 Emergency Department Patients in 46 Countries: The RE-LY Atrial Fibrillation RegistryOLDGREN, Jonas; HEALEY, Jeff S; LISHENG LIU et al.Circulation (New York, N.Y.). 2014, Vol 129, Num 15, pp 1568-1576, issn 0009-7322, 9 p.Article

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyCONNOLLY, Stuart J; WALLENTIN, Lars; AVEZUM, Alvaro et al.Circulation (New York, N.Y.). 2013, Vol 128, Num 3, pp 237-243, issn 0009-7322, 7 p.Article

Apixaban with Antiplatelet Therapy after Acute Coronary SyndromeALEXANDER, John H; LOPES, Renato D; HUBER, Kurt et al.The New England journal of medicine. 2011, Vol 365, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/ TRANSCEND) TrialsBÖHM, Michael; BAUMHÄKEL, Magnus; LISHENG LIU et al.Circulation (New York, N.Y.). 2010, Vol 121, Num 12, pp 1439-1446, issn 0009-7322, 8 p.Article